Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol
Year: 2017
Type: article
Study design: Observational Study
Source: European Heart Journal
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Pfizer, AstraZeneca, Sanofi, Kowa Company
OpenAlex ID: W2731425052
